Education
About Us
Working with TipRanks
Follow Us
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -26.68M | $ -21.27M | $ -14.00M | $ -13.65M | $ -12.70M |
| EBITDA | $ -26.64M | $ -21.24M | $ -13.98M | $ -13.62M | $ -12.68M |
| Net Income | $ -24.44M | $ -19.38M | $ -13.68M | $ -13.59M | $ -12.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 44.15M | $ 52.90M | $ 33.50M | $ 45.11M | $ 27.51M |
| Total Assets | $ 46.34M | $ 54.16M | $ 34.40M | $ 45.55M | $ 28.09M |
| Total Debt | $ 340.00K | $ 400.00K | $ 469.00K | $ 52.00K | $ 118.00K |
| Net Debt | $ -2.69M | $ -4.14M | $ -4.26M | $ -4.66M | $ -7.29M |
| Total Liabilities | $ 5.63M | $ 3.10M | $ 2.57M | $ 1.53M | $ 2.08M |
| Stockholders' Equity | $ 40.72M | $ 51.06M | $ 31.83M | $ 44.02M | $ 26.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.10M | $ -18.75M | $ -11.59M | $ -12.27M | $ -9.23M |
| Operating Cash Flow | $ -22.08M | $ -18.73M | $ -11.51M | $ -12.25M | $ -9.19M |
| Investing Cash Flow | $ 8.56M | $ -18.30M | $ 11.54M | $ -20.54M | $ -16.13M |
| Financing Cash Flow | $ 11.99M | $ 36.84M | $ -6.00K | $ 30.09M | $ 28.84M |